UBNow features Dr. Rebecca Ashare!

ENABLE Lab’s Dr. Rebecca Ashare shares her perspective on the rescheduling of cannabis by the Drug Enforcement Administration to a Schedule III substance and how it will impact the feasibility of generating high-quality rigorous research. For the full article, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *